Immune responses in children after vaccination with a typhoid Vi-tetanus toxoid conjugate vaccine in Bangladesh by Khanam, F, Babu, G, Rahman, N, Liu, X, Rajib, NH, Ahmed, SU, Hossen, MI, Biswas, PK, Kelly, S, Thesis-Nyland, K, Mujadidi, Y, McMillan, NAJ, Pollard, AJ, Clemens, JD, Qadri, F

Successful integration of newborn genetic testing into UK routine screening using prospective consent to determine eligibility for clinical trials by Bendor-Samuel, OM, Wishlade, T, Willis, L, Aley, P, Choi, E, Craik, R, Mujadidi, Y, Mounce, G, Roseman, F, De La Horra Gozalo, A, Bland, J, Taj, N, Smith, I, Ziegler, A-G, Bonifacio, E, Winkler, C, Haupt, F, Todd, JA, Servais, L, Snape, MD, Vatish, M

Safety and immunogenicity of the ChAdOx1 nCoV-19 (AZD1222) vaccine in children aged 6–17 years: a preliminary report of COV006, a phase 2 single-blind, randomised, controlled trial... by Li, G, Cappuccini, F, Marchevsky, NG, Aley, PK, Aley, R, Anslow, R, Bibi, S, Cathie, K, Clutterbuck, E, Faust, SN, Feng, S, Heath, PT, Kerridge, S, Lelliott, A, Mujadidi, Y, Ng, KF, Rhead, S, Roberts, H, Robinson, H, Roderick, MR, Singh, N, Smith, D, Snape, MD, Song, R, Tang, K, Yao, A, Liu, X, Lambe, T, Pollard, AJ

Single-dose administration and the influence of the timing of the booster dose on immunogenicity and efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine: a pooled analysis of four random... by Voysey, M, Costa Clemens, SA, Madhi, SA, Folegatti, PM, Aley, PK, Angus, B, Bibi, S, Cicconi, P, Clutterbuck, EA, Dold, C, Emary, KRW, Ewer, KJ, Flaxman, A, Feng, S, Green, CM, Greenland, M, Jenkin, D, Joe, CCD, Kerridge, S, Marchevsky, NG, Minassian, AM, Mujadidi, Y, Phillips, DJ, Plested, E, Ramasamy, M, Ritchie, AJ, Robinson, H, Song, R, Snape, MD, Douglas, AD, Hill, AVS, Lambe, T, Gilbert, SC, Pollard, AJ

Safety and immunogenicity of the ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 in HIV infection: a single-arm sub-study of a phase 2/3 clinical trial by Frater, J, Ewer, K, Ogbe, A, Pace, M, Adele, S, Adland, E, Aley, P, Ali, M, Ansari, M, Bittaye, M, Brown, A, Brown, H, Cappuccini, F, Dejnirattisai, W, Dold, C, Moreira Folegatti, P, Fowler, J, Jenkin, D, Makinson, R, Marchevsky, N, Mujadidi, Y, Parolini, L, Plested, E, Ramasamy, M, Rhead, S, Robinson, H, Robinson, N, Rongkard, P, Tipoe, T, Zacharopoulou, P, Barnes, E, Goulder, P, Klenerman, P, Screaton, G, Hill, A, Gilbert, S, Pollard, AJ, Lambe, T

Phase 1/2 trial of SARS-CoV-2 vaccine ChAdOx1 nCoV-19 with a booster dose induces multifunctional antibody responses by Barrett, J, Belij-Rammerstorfer, S, Dold, C, Ewer, KJ, Folegatti, PM, Gilbride, C, Halkerston, R, Hill, J, Jenkin, D, Stockdale, L, Verheul, MK, Aley, PK, Angus, B, Bellamy, D, Berrie, E, Bibi, S, Bittaye, M, Carroll, MW, Cavell, B, Clutterbuck, EA, Edwards, N, Flaxman, A, Fuskova, M, Gorringe, A, Hallis, B, Kerridge, S, Lawrie, AM, Linder, A, Liu, X, Madhavan, M, Makinson, R, Mellors, J, Minassian, A, Moore, M, Mujadidi, Y, Plested, E, Poulton, I, Ramasamy, MN, Robinson, H, Rollier, CS, Song, R, Snape, MD, Tarrant, R, Taylor, S, Thomas, KM, Voysey, M, Watson, MEE, Wright, D, Douglas, AD, Green, CM, Hill, AVS, Lambe, T, Pollard, AJ

Safety and immunogenicity of ChAdOx1 nCoV-19 vaccine administered in a prime-boost regimen in young and old adults (COV002): a single-blind, randomised, controlled, phase 2/3 trial by Ramasamy, MN, Minassian, AM, Ewer, KJ, Flaxman, AL, Folegatti, PM, Owens, DR, Voysey, M, Aley, PK, Angus, B, Babbage, G, Belij-Rammerstorfer, S, Berry, L, Bibi, S, Bittaye, M, Cathie, K, Chappell, H, Charlton, S, Cicconi, P, Clutterbuck, EA, Colin-Jones, R, Dold, C, Emary, KRW, Fedosyuk, S, Fuskova, M, Gbesemete, D, Green, C, Hallis, B, Hou, MM, Jenkin, D, Joe, CCD, Kelly, EJ, Kerridge, S, Lawrie, AM, Lelliott, A, Lwin, MN, Makinson, R, Marchevsky, NG, Mujadidi, Y, Munro, APS, Pacurar, M, Plested, E, Rand, J, Rawlinson, T, Rhead, S, Robinson, H, Ritchie, AJ, Ross-Russell, AL, Saich, S, Singh, N, Pollard, AJ, Oxford COVID Vaccine Trial Group

Safety, tolerability, viral kinetics, and immune correlates of protection in healthy, seropositive UK adults inoculated with SARS-CoV-2: a single-centre, open-label, phase 1 contro... by Jackson, S, Marshall, JL, Mawer, A, Lopez-Ramon, R, Harris, SA, Satti, I, Hughes, E, Preston-Jones, H, Cabrera Puig, I, Longet, S, Tipton, T, Laidlaw, S, Doherty, RP, Morrison, H, Mitchell, R, Tanner, R, Ateere, A, Stylianou, E, Wu, M-S, Fredsgaard-Jones, TPW, Breuer, J, Rapeport, G, Ferreira, VM, Gleeson, F, Pollard, AJ, Carroll, M, Catchpole, A, Chiu, C, McShane, H, Alparaque, M, Anid, L, Barnes, E, Benamore, R, Bharti, N, Patel, B, Burns, A, Byard, N, Conway, O, Cooper, C, Crowther, C, Dunachie, SJ, Johnstone, T, Jose, J, Luciw, M, Mujadidi, Y, Nehiweze, A, Nyamunda, S, Orobiyi-Rieba, M, Parvelikudy, B, Platt, A